In pharma M&A, 2015 trumps red-hot 2014 so far, report says

Carly Helfand

Global activity in the , medical and biotech spheres over the first three quarters of this year has hit its largest-to-date value since at least 2001, according to new data from intelligence and news service Mergermarket. Over that range, the industries have turned up 954 transactions worth $ 367.6 billion.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS